欢迎访问《标记免疫分析与临床》官方网站!
综述

前列腺癌基因3的研究进展

展开
  • 南京医科大学附属南京医院(南京市第一医院)泌尿外科,南京 210006

收稿日期: 2014-07-14

  修回日期: 2014-09-15

  网络出版日期: 2014-11-06

基金资助

南京医科大学生殖医学国家重点实验室开放基金课题资助(SKLRM-KF-1103)

Research Progress of Prostate Cancer Gene 3

Expand
  • Department of Urology, Nanjing First Hospital, Nanjing 210006, China

Received date: 2014-07-14

  Revised date: 2014-09-15

  Online published: 2014-11-06

摘要

前列腺癌的早期诊断、鉴别诊断目前仍面临许多挑战。前列腺癌基因3 (PCA3)为近年来发现的一种前列腺癌组织高特异性标记物,引起了国内外学者的关注。本文就其分子生物学特性、以及在前列腺癌诊断、治疗中的应用进展进行综述。

本文引用格式

谭思嘉,贾瑞鹏 . 前列腺癌基因3的研究进展[J]. 标记免疫分析与临床, 2014 , 21(5) : 608 . DOI: 10.11748/bjmy.issn.1006-1703.2014.05.031

Abstract

Early diagnosis, differential diagnosis of prostate cancer is still facing many challenges. Prostate cancer gene 3 (PCA3) is a highly specific prostate cancer marker found in recent years, and got the attention of domestic and foreign scholars. The progress of molecular biological characteristics of PCA3, and its applications in diagnosis and treatment of prostate cancer were reviewed.
文章导航

/